Abridge Reaches $5.3B Valuation After Years of Building AI Healthcare Platform

Abridge CEO and co-founder Shiv Rao says the company spent nearly five years navigating uncertainty before finding product-market fit in the rapidly evolving artificial intelligence healthcare sector.

Speaking on the “20VC” podcast, Rao reflected on the challenges of building a generative AI healthcare platform before the broader market was ready to adopt the technology at scale.

Abridge recently reached a $5.3 billion valuation following a $300 million funding round backed by high-profile investors including Jensen Huang, Henry Kravis, Bessemer Venture Partners, Union Square Ventures, and investor Elad Gil.

Founded by Rao, who continues to practice as a cardiologist, Abridge has grown to approximately 450 employees while expanding partnerships with major US healthcare systems, including Emory Healthcare and Yale New Haven Health.

The company specializes in AI-powered clinical documentation tools designed to reduce administrative workloads for physicians by automatically generating medical notes during patient interactions.

According to Rao, generative AI adoption in healthcare has shifted rapidly from experimental technology to what he described as “table stakes” for leading medical institutions.

During the discussion, Rao emphasized that Abridge’s long-term competitive advantage will depend less on foundation models themselves and more on deep healthcare integration, workflow reliability, and trust among clinicians.

He also pushed back against concerns that artificial intelligence will replace physicians, arguing instead that AI systems are more likely to augment doctors by reducing repetitive administrative tasks and allowing clinicians to spend more time with patients.

Rao noted that Abridge has no intention of monetizing patient data, describing privacy and trust as critical components of the company’s strategy as AI adoption accelerates across the healthcare industry.

The interview also highlighted broader themes shaping the next phase of AI startups, including disciplined scaling, hiring high-judgment executives, and maintaining operational efficiency even after large funding rounds.